Table 1.
References | HTST treatment parameters | Device | Milk components/properties | Impact of treatment (compared to raw milk) | Comparison HTST – HoP | |
---|---|---|---|---|---|---|
Pathogens Microbicidal/Antimicrobial activity |
Capriati et al. (27) | Fixed time/temperature: 70°C for few min. (not specified) pasteurized volume: 30 mL each batch Donors n = 2 |
Submerged bottles in a HoP pasteuriser modified to reach the determined plateau temperature. | Microbiological counts of native milk microflora (Total aerobic, Staphylococcus aureus, Bacillus cereus) | Undetectable after treatment (except B. cereus – one sample) | Similar eradication in HoP |
Aceti et al. (28) | Fixed time/temperature: 72°C for 15 s pasteurized volume total: 100 mL Donors n = 5 |
Patented prototype (EP 15176792.8–1,358). | Microbiological counts of native milk microflora (Total aerobic, Staphylococcus aureus, Enterobacteriaceae) | Undetectable microbial counts after treatment | Similar eradication in HoP | |
Manzardo et al. (26) | Different time/ temperature combinations: 62 and 81°C for 5 s. pasteurized volume 60 mL each batch Donors n = 30 |
Virex II (Lauf, Tübingen, Germany) | Efficacy against inoculated microorganisms | Combination 81°C/5 s. resulted in no bacterial growth, with the exception of E. faecalis | HoP: 5 log reduction for all microorganisms except C. sakazakii (RV00078) | |
Enterococcus faecalis ATC 29212–5.8 × 104 CFU/mL | 62°C for 5 s: 0.76 log reduction; 81°C for 5 s: 3.3 log reduction | |||||
Cronobacter sakazakii RV00078 and RV5-I-92 – 1.4 and 2.1 × 105 CFU/mL | 62°C for 5 s: 1.9 and 1.3 log reduction; 81°C for 5 s: 5 log reduction | |||||
Listeria monocytogenes 00218 and 0015–1.8 and 1.1 × 105 CFU/mL | 62°C for 5 s: 1.2 and 1 log reduction; 81°C for 5 s: 5 log reduction | |||||
Cytomegalovirus (HCMV) | As effective as raw human milk | |||||
Respiratory syncytial virus (RSV) | As effective as raw human milk | |||||
Rotavirus (HRoV) | As effective as raw human milk | |||||
Rhinovirus (HRhV) | Reduced inhibitory dilution (HTST 0.06 vs. Raw 0.02) | |||||
Herpes simplex virus type 1 and 2 (HSV-1, HSV-2) | As effective as raw human milk against HSV-2; reduced inhibitory dilution against HSV-1 (HTST 0.08 vs. Raw 0.05) | |||||
Patil et al. (29) | Fixed time/temperature: 72°C for 15 s. pasteurized volume: 10 mL each batch Donors n = 48, pooled |
Submerged bottles in a HoP pasteuriser modified to reach the determined plateau temperature: | Bactericidal activity against E. coli |
Reduction in bacterial growth:
|
HoP showed a higher E. coli bactericidal activity than HTST after 24 h incubation (46%) | |
Kontopodi et al. (24) | Fixed time/temperature: 72°C for 15 s. pasteurized volume total: 50 mL Donors n = 4, pooled |
Laboratory scale pasteuriser | Bacteriostatic activity against E. coli and S. aureus | Growth rate per hour: significant increase in E. coli growth rate (HTST 4.2 vs. Raw 3.6), but similar for S. areus (growth rate 2.0 -fold per hour) | HoP caused the highest reduction in bacteriostatic capacity. |
*p-value are indicated only when significant and/or reported in the original article; NS, not significantly different.